Log In
Print this Print this

Ventavis, iloprost

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionInhaled prostacyclin analog
Molecular Target Endothelin receptor
Mechanism of ActionEndothelin receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat New York Heart Association (NYHA) class III and IV pulmonary hypertension (PAH); Treat New York Heart Association (NYHA) class IV pulmonary hypertension (PH); Treat primary pulmonary hypertension (PPH); Treat pulmonary arterial hypertension (PAH); Treat pulmonary hypertension (PH); Treat pulmonary hypertension (PH) associated with idiopathic pulmonary fibrosis (IPF)
Regulatory Designation U.S. - Orphan Drug (Treat pulmonary arterial hypertension (PAH))
PartnerActelion Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today